BackgroundSystemic sclerosis (SSc) is a multisystem, connective tissue disease characterized by fibrosis of the skin and internal organ involvement, which can influence quality-of-life and functional capacity. 1 The mortality rate is increasing in the United States and Europe; as many as 3.08 persons are affected per 1 million. Changes in lungs and heart, pulmonary hypertension are the most significant reasons of death in patients with systemic sclerosis.2ObjectivesTo estimate quality and completeness of medical care in patients with systemic sclerosis in Russia.Methods66 patients included in the study. 61 female and 5 male (mean age: 62,48 ± 10,1), among which there were 24 limited SSc (lSSc) and 42 diffuse SSc (dSSc). All patients fulfilled the ACR/EULAR classification criteria. We estimated percentage of patients, who were examined by basic studies: capillaroscopy, functional lung tests, echocardiography, HRCT, fully immunologic study and right heart catheterization etc. and try to understand reasons of incompleteness of these assessments.ResultsDespite the presence of Raynaud’s phenomenon in 85% of patients, capillaroscopy was performed only in 65.21% of them, examination of the esophagus was performed in only 22.92% of patients, with development of dysphagia in 50% of patients. HRCT was performed in 54.71% (25.76% NSIP, 9.09% UIP), right heart catheterization in 4.17% (signs of pulmonary hypertension according to ECHO detected in 42.86% of patients). FLT were performed in mostly patients (86.34%), but it wasn`t fully: measuring of DLCO was realized only in patients with severe desease (22.92% оf patients). That explains its low mean level (61.37% from normal) as opposed to mean FEV1 (90.7% from normal) and FVC (89.47% from normal) level. Fully immunologic study was performed in 35.42% of patients, despite the fact that different autoantibodies showed up in 72.92% of patients (the most common were: antiScl70 41,67%, ACA 22,92%, ANF 52,08%).ConclusionAccording to the results of the study, we have identified a significant decrease in the quality of medical care despite the clinical recommendations and generally accepted standards. We suppose. that the main reasons for this situation are the complex healthcare problems: insufficient competence of doctors, lack of collaboration between related specialties, unavailability of a number of studies within the framework of free medicine and high cost of these studies for the patients themselves, and the lack of time for communication between the doctor and the patient to explain the seriousness of the disease and the nescessity of all parts of examination and treatment.References[1]Almeida C, Almeida I, Vasconcelos C. Quality of life in systemic sclerosis. Autoimmun Rev. 2015;14(12):1087-1096[2]Ungprasert P, Srivali N, Kittanamongkolchai W. Systemic sclerosis and risk of venous thromboembolism: A systematic review and meta-analysis. Mod Rheumatol. 2015 Apr 7. 1-17.Disclosure of InterestsNone declared
BackgroundSystemic sclerosis (SSc) is a multisystem, connective tissue disease characterized by fibrosis of the skin and internal organ involvement, which can influence quality of life and functional capacity. SSc patients show some problems associated with reduced quality of life.ObjectivesSystemic sclerosis (SSc) is a multisystem, connective tissue disease characterized by fibrosis of the skin and internal organ involvement, which can influence quality of life and functional capacity. SSc patients show some problems associated with reduced quality of life.MethodsIn total, 51 patients with SSc were included: 50 women and 1 man (mean age: 63,2 ± 10,1 year, limited SSc 28/diffuse SSc 23, median duration since first non-Raynaud symptom: 10,1 years) who fulfilled the ACR/EULAR classification criteria (2013), filled in questionnaires assessing disability (HAQ, Health Assessment Questionnaire) and quality of life (SF-36, Medical outcomes study Short Form 36 - Physical Component Summary and Mental Component Summary).ResultsAverage HAQ in patients with limited and diffuse SSc was 0,66±0,58 and 0,9±0,59. Data analysis showed that 59% of the patients were in the mild to moderate HAQ disability category (0 ⩽ HAQ < 1), 39% in the moderate to severe disability category (1 ⩽ HAQ < 2), and 2% in the severe to very severe disability category (2 ⩽ HAQ ⩾ 3). The SF36 mean scores of the total group were 34,8±8,7 on the Mental Component Summary and 37,0±13,1 on the Physical Component Summary.ConclusionSsc and its complications decrease quality of life and functional capacity. Although validated in SSc, the HAQ disability index underestimates respiratory failure due to interstitial lung disease, gastrointestinal symptoms, cardiovascular complications and severity of Raynaud phenomenon. Alternative measures of functional impairment should be examined. Health-related quality of life, which was assessed by the SF-36 is reduced in both physical and mental domains. It should be taken into account by clinicians for further improvement of treatment and development rehabilitation program.References[1]Almeida C, Almeida I, Vasconcelos C. Quality of life in systemic sclerosis. Autoimmun Rev. 2015;14(12):1087-1096Disclosure of InterestsNone declared
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.